Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macular degeneration: how big is the problem?

E Cheraskin1

  • 1University of Alabama Medical Center, Birmingham.

Journal of the National Medical Association
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Importance of the Basic Sciences.

Newsmonthly. American Dental Society of Anesthesiology·2009
Same author

What is "normalization" of blood glucose?

Southern medical journal·1996
Same author

Antioxidants and lupus erythematosis.

Journal of the Royal Society of Health·1996
Same author

Antioxidants in health and disease.

Journal of the American Optometric Association·1996
Same author

Vitamin C, smoking and SIDS.

Journal of the Royal Society of Health·1995
Same author

The vitamin C connection.

Diabetic medicine : a journal of the British Diabetic Association·1995

Macular degeneration is a leading cause of blindness in the elderly, yet its epidemiology is poorly understood. Viewing macular degeneration as a continuum, rather than a binary condition, suggests it is more prevalent and may allow for earlier detection and intervention.

Area of Science:

  • Ophthalmology
  • Epidemiology
  • Geriatrics

Background:

  • Macular degeneration is a primary cause of vision loss in the elderly in the US and Europe.
  • Current understanding and reporting of macular degeneration often overlook its complex nature, focusing on limited prevalence data.
  • There are no established methods to slow, stop, reverse, or prevent macular degeneration.

Purpose of the Study:

  • To highlight the lack of comprehensive epidemiologic data on macular degeneration.
  • To challenge the traditional binary view of macular degeneration, proposing it exists on a continuum.
  • To emphasize the importance of early recognition for potential cure or prevention.

Main Methods:

  • Review of existing literature on macular degeneration prevalence and incidence.

Related Experiment Videos

  • Conceptual analysis of macular degeneration as a disease spectrum rather than a dichotomous condition.
  • Epidemiological data interpretation considering a continuum model.

    • Main Results:

    • Prevalence data for macular degeneration is limited and often based on a simplistic black-and-white classification.
    • Incidence data for macular degeneration is largely unavailable.
    • Viewing macular degeneration as an achromatic continuum indicates a higher prevalence than commonly reported.

    Conclusions:

    • The current understanding of macular degeneration epidemiology is insufficient.
    • A continuum model for macular degeneration suggests it is more prevalent than previously thought.
    • Earlier detection of macular degeneration across its spectrum could improve treatment outcomes and prevention strategies.